After record profits and strong growth in 2023, the industry''s momentum faced limitations in 2024 due to rising raw material costs and increased market competition.
The national strategy for developing Việt Nam''s pharmaceutical industry targets that by 2045, the total value of the pharmaceutical industry contributing to Việt Nam''s GDP is over US$20 billion.
The pharmaceutical industry is growing steadily because input costs are stable compared to other industries and businesses are less affected in a high inflation environment.
Nguyen Van Phung, director of the Department of Tax Administration at Large Enterprises from the General Department of Taxation, spoke with Viet Nam News about incentive tax policies for Indian corporations investing in the Vietnamese pharmaceutical industry
Pharmaceutical stocks are experiencing an upsurge as fears of coronavirus have boosted demand for healthcare products and services, lifting demand for shares.
Eurocham highly values the potential of Viet Nam to become a centre for the research-based pharmaceutical industry including production, export and supplies of high quality healthcare services.
Significant potential for growth in trade in pharmaceutical and healthcare products exists between India and Viet Nam, experts at the Indian Pharmaceutical Exhibition and B2B Interaction said yesterday (Jan 21) in HCM City.
Vietnamese pharmaceutical companies are optimistic about the business prospects of the sector, with nearly 80 per cent of firms anticipating an annual industry growth rate of more than 10 per cent.